Purpose of review: While the distinctive motor symptoms of Parkinson disease (PD) have been described for centuries, cognitive impairment has only recently been recognized as a central feature. Studies have yielded clues to the etiology and natural history of cognitive impairment in PD, but much remains unclear and effective therapies are needed. Recent findings: Longitudinal cohort studies demonstrate that almost all patients with PD will develop dementia if they live long enough. New CSF biomarker and genetic studies suggest that it may soon be possible to forecast and track the progression of dementia in PD. Sleep and sleep disturbance appear to be intrinsically linked with PD, although the implications for individual outcomes and opportunities for intervention are unclear. Multidisciplinary treatment approaches incorporating cognitive training may help to improve outcomes. Summary: We review several recent advances in understanding the pathophysiology, genetics, and management of cognitive impairment in PD.

Original languageEnglish
Pages (from-to)452-458
Number of pages7
JournalNeurology: Clinical Practice
Issue number5
StatePublished - Oct 1 2016


Dive into the research topics of 'Parkinson disease and cognitive impairment: Five new things'. Together they form a unique fingerprint.

Cite this